Showing results (271-280 of 590) with videos related to

Sort By:
Pageof 59
Cells|August 27, 2021
Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by CoronavirusesYves Pacheco, Dominique Valeyre, Thomas El Jammal, et al.
The European Respiratory Journal|June 1, 2023
Treatable traits: a comprehensive precision medicine approach in interstitial lung diseaseYet H Khor, Vincent Cottin, Anne E Holland, et al.
Chest|May 26, 2020
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary FibrosisAyodeji Adegunsoye, Shehabaldin Alqalyoobi, Angela Linderholm, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2015
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary FibrosisJustin M Oldham, Shwu-Fan Ma, Fernando J Martinez, et al.
Panminerva Medica|January 26, 2021
IC4: a new combined predictive index of mortality in idiopathic pulmonary fibrosisAngelo Zinellu, Claudia Collu, Elisabetta Zinellu, et al.
ERJ Open Research|October 27, 2018
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT studyVincent Cottin, Dirk Koschel, Andreas Günther, et al.
American Journal of Respiratory and Critical Care Medicine|August 2, 2008
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trialGanesh Raghu, Kevin K Brown, Ulrich Costabel, et al.
Annals of the Rheumatic Diseases|April 30, 2026
Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trialAnna-Maria Hoffmann-Vold, Shervin Assassi, Vincent Cottin, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseasesVincent Cottin, Nikhil A Hirani, David L Hotchkin, et al.
Pageof 59